scorecardresearchAurobindo Pharma Share Price Live NSE, BSE, Today - Aurobindo Pharma Stock Price
Mintgenie

Aurobindo Pharma

BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01037 | SECTOR: Major Drugs

₹403.90 -6.00 (-1.46%)

03 Feb 2023, 10:23 (IST)

  • Open

    407.55

  • High

    411.45

  • Low

    397.30

  • Prev Close

    409.90

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    -

  • Volume

    38.26K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    403.90

  • Ask

    -
View all metrics

Promoter Pledge Holding - 8.37%

Promoter NameNo of SharesPercentage
K NITYANANDA REDDY1,00,55,0001.71%
KIRTHI REDDY KAMBAM19,00,0000.32%
KAMBAM SPOORTHI4,00,0000.06%
KOTTAMANCHI RAJESHWARI2,00,0000.03%
M SUMANTH KUMAR REDDY8,00,0000.13%
RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING)3,11,95,8625.32%
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING)37,50,0000.63%
PRASADA REDDY KAMBHAM1,00,0000.01%
AXIS CLINICALS LIMITED6,58,0000.11%

Company Description

  • Major Drugs

  • BSE

    524804

  • NSE

    AUROPHARMA

  • ISIN

    INE406A01037

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company develops, manufactures and distributes generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients. Its product portfolio is spread over seven therapeutic/product areas encompassing central nervous systems (CNS), anti-retroviral, cardiovascular (CVS), antibiotics, gastroenterological, anti-diabetics and anti-allergic. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited and Aurolife Pharma LLC, among others.

Company Officers

  • K. Nityananda Reddy

    Vice Chairman of the Board, Managing Director

  • Santhanam Subramanian

    Chief Financial Officer

  • B. Adi Reddy

    Compliance Officer, Company Secretary

  • M. Madan Reddy

    Whole-Time Director

  • P. Sarath Reddy

    Whole-Time Director

  • M. Sivakumaran

    Whole-Time Director